MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Microarray analysis upon an synthetic α-synuclein induced model reveals some susceptibility genes in Parkinson’s disease

E. Tao (Guangzhou, China)

Meeting: 2018 International Congress

Abstract Number: 1347

Keywords: Alpha-synuclein

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Genetics

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: To uncover new disease-associated genes and their relevant mechanisms in the pathogenetic process of neurodegenerative disorders, we carried out a gene microarray analysis based on a Parkinson’s disease (PD) in vitro model induced by α-synuclein oligomers.

Background: The gene microarray was performed upon the cellular model induced by 25 mol/L α-synuclein oligomers, which has been confirmed to show the stable, transmissible neurotoxicity of α-synuclein, a typical PD pathological marker. And the different expressed long non-coding RNA(lncRNA) was screened out for the reseach of its potential influence upon the pathogenetic process of neurodegenerative disorders.

Methods: Immumofluorescence and electron microscope were used to make sure α-synuclein have already entered the cells and led to α-synuclein lesions. The expression of lncRNAs and mRNAs is analyzed by gene microarray and GeneSpring GX v12.1 software package. Differently-expressed genes(DEGs) were verified by real time qPCR and the selected genes were studied by ceRNA(competing endogenous RNAs) analysis.

Results: A significant differentially expressed lncRNAs, G069488, were chosen as a breakthrough point for the further research because it was located to the gene NEED9, which is relative to the axon growth and neurodevelopment closely. Subsequent verified qPCR experiment determined the same variation trend as the result of microarray analysis showed.

Conclusions: The results of the present study widen our horizon of PD susceptibility genes and provide new pathways towards efficient diagnostic biomarkers and therapeutic targets for PD.

To cite this abstract in AMA style:

E. Tao. Microarray analysis upon an synthetic α-synuclein induced model reveals some susceptibility genes in Parkinson’s disease [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/microarray-analysis-upon-an-synthetic-%ce%b1-synuclein-induced-model-reveals-some-susceptibility-genes-in-parkinsons-disease/. Accessed May 18, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/microarray-analysis-upon-an-synthetic-%ce%b1-synuclein-induced-model-reveals-some-susceptibility-genes-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley